Literature DB >> 7543585

Detection of an RNase H activity associated with hepadnaviruses.

S M Oberhaus1, J E Newbold.   

Abstract

Replication of the hepadnavirus DNA genome is accomplished via reverse transcription of an intermediate, pregenomic RNA molecule. This process is likely to be carried out by a virally encoded, multifunctional polymerase which possesses DNA- and RNA-dependent DNA polymerase and RNase H activities. However, the nature of the product(s) of the polymerase gene predicted to mediate these functions is unclear. Biochemical studies of the polymerase protein(s) have been limited by its apparent low abundance in virus particles and, until recently, the inability to express active polymerase protein(s) heterologously. We have used activity gel assays to detect DNA- and RNA-dependent DNA polymerase activities associated with highly purified duck hepatitis B virus (DHBV) core particles (S. M. Oberhaus and J. E. Newbold, J. Virol. 67:6558-6566, 1993). Now we report that the same approach identifies a 35-kDa RNase H activity in association with highly purified DHBV core particles and crude preparations of virions from DHBV-infected ducks and woodchuck hepatitis virus-infected woodchucks. This is the first report of the detection of an hepadnavirus-associated RNase H activity. Its apparent size is smaller than any of the DNA polymerase activities that we detected previously and significantly smaller than the full-length protein predicted from the polymerase open reading frame (p85 for DHBV). These data suggest that the viral polymerase and RNase H activities are separable and that these enzymes may coordinate their activities in vivo by forming a complex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543585      PMCID: PMC189429     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Duck hepatitis B virus can tolerate insertion, deletion, and partial frameshift mutation in the distal pre-S region.

Authors:  J S Li; L Cova; R Buckland; V Lambert; G Deléage; C Trépo
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

2.  The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis.

Authors:  G H Wang; C Seeger
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

Review 3.  Retroviral reverse transcriptase: synthesis, structure, and function.

Authors:  S P Goff
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

4.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

5.  On the molecular weight and subunit composition of calf thymus ribonuclease H1.

Authors:  Y W Rong; P L Carl
Journal:  Biochemistry       Date:  1990-01-16       Impact factor: 3.162

6.  Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity.

Authors:  G Radziwill; W Tucker; H Schaller
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein.

Authors:  F Birnbaum; M Nassal
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging.

Authors:  H J Schlicht; R Bartenschlager; H Schaller
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

9.  Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.

Authors:  A Hizi; S H Hughes; M Shaharabany
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

10.  HIV-1 RT-associated ribonuclease H displays both endonuclease and 3'----5' exonuclease activity.

Authors:  O Schatz; J Mous; S F Le Grice
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

View more
  5 in total

1.  Chronic hepatitis B: what should be the goal for new therapies?

Authors:  Timothy M Block; Robert Gish; Haitao Guo; Anand Mehta; Andrea Cuconati; W Thomas London; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2013-02-04       Impact factor: 5.970

2.  Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides.

Authors:  Peter Hasselblatt; Birgit Hockenjos; Christian Thoma; Hubert E Blum; Wolf-Bernhard Offensperger
Journal:  Nucleic Acids Res       Date:  2005-01-07       Impact factor: 16.971

3.  Evidence that the RNAseH activity of the duck hepatitis B virus is unable to act on exogenous substrates.

Authors:  Y Gong; E Yao; J E Tavis
Journal:  BMC Microbiol       Date:  2001-07-19       Impact factor: 3.605

4.  A hybrid chimeric system for versatile and ultra-sensitive RNase detection.

Authors:  Stefano Persano; Giuseppe Vecchio; Pier Paolo Pompa
Journal:  Sci Rep       Date:  2015-04-01       Impact factor: 4.379

5.  Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma.

Authors:  R Chauhan; N D Churchill; P M Mulrooney-Cousins; T I Michalak
Journal:  Oncogenesis       Date:  2017-04-17       Impact factor: 7.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.